Osteosarcoma Cells and Undifferentiated Human Mesenchymal Stromal Cells Are More Susceptible to Ferroptosis than Differentiated Human Mesenchymal Stromal Cells
Antioxidants · 06.02.2025 · 14 (2) · 189
DOI: 10.3390/antiox14020189 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants, online erschienen am 06.02.2025. Verfasst von Yuliya D Smirnova und 10 weiteren Autor:innen. Beteiligte Einrichtung: Ludwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA, 1200 Vienna, Austria. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: OeAD-GmbH, European Union's Horizon 2020; H2020-NMBP-TR-IND-2020, Austrian Research Promotion Agency (FFG).
Abstract (Originalsprache)
Current research suggests that promoting ferroptosis, a non-apoptotic form of cell death, may be an effective therapy for osteosarcoma, while its inhibition could facilitate bone regeneration and prevent osteoporosis. Our objective was to investigate whether the susceptibility to and regulation of ferroptosis differ between undifferentiated (UBC) and differentiated (DBC) human bone marrow stromal cells, as well as human osteosarcoma cells (MG63). Ferroptosis was induced by either inhibiting glutathione peroxidase 4 (GPX4) using RSL3 or blocking all glutathione-dependent enzymes through inhibition of the glutamate/cysteine antiporter with Erastin. Lipid peroxidation was assessed using the fluorescent probe BODIPY™581/591C11, while Ferrostatin-1 was used to inhibit ferroptosis. We demonstrate that neither Erastin nor RSL3 induces ferroptosis in DBC. However, both RSL3 and Erastin induce ferroptosis in UBC, while Erastin predominantly induces ferroptosis in MG63 cells. Our data suggest that ferroptosis induction in undifferentiated hBMSCs is primarily regulated by GPX4, whereas glutathione S-Transferase P1 (GSTP1) plays a key role in controlling ferroptosis in osteosarcoma cells. In conclusion, targeting the key pathways involved in ferroptosis across different bone cell types may improve the efficacy of cancer treatments while minimizing collateral damage and supporting regenerative processes, with minimal impact on cancer therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Ludwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA, 1200 Vienna, Austria.
- Austrian Cluster for Tissue Regeneration, 1200 Vienna, Austria.
- Laboratory of Metagenomics and Food Biotechnology, Voronezh State University of Engineering Technologies, 394036 Voronezh, Russia.
- Institute for Medical Biochemistry, University of Veterinary Medicine Vienna, 1210 Vienna, Austria.
ORCID-Profile: Yuliya D Smirnova, Dominik Hanetseder, Regina Brunauer, Johanna Catharina Duvigneau, Andrey V Kozlov
Förderung
- OeAD-GmbH
- European Union's Horizon 2020; H2020-NMBP-TR-IND-2020
- Austrian Research Promotion Agency (FFG)
- Austrian Science Fund (FWF)
- Stipendienstiftung der Republik Österreich
- European Union’s Horizon 2020
Zitieren
APA
Smirnova, Y. D., Hanetseder, D., Derigo, L., Gasser, A. S., Vaglio-Garro, A., Sperger, S., Brunauer, R., Korneeva, O. S., Duvigneau, J. C., Marolt Presen, D., & Kozlov, A. V. (2025). Osteosarcoma Cells and Undifferentiated Human Mesenchymal Stromal Cells Are More Susceptible to Ferroptosis than Differentiated Human Mesenchymal Stromal Cells. Antioxidants, 14(2), 189. https://doi.org/10.3390/antiox14020189
Vancouver
Smirnova YD, Hanetseder D, Derigo L, Gasser AS, Vaglio-Garro A, Sperger S, et al. Osteosarcoma Cells and Undifferentiated Human Mesenchymal Stromal Cells Are More Susceptible to Ferroptosis than Differentiated Human Mesenchymal Stromal Cells. Antioxidants. 2025;14(2):189. doi:10.3390/antiox14020189
BibTeX
@article{Smirnova2025,
author = {Smirnova, Yuliya D and Hanetseder, Dominik and Derigo, Lukas and Gasser, Andreas Sebastian and Vaglio-Garro, Annette and Sperger, Simon and Brunauer, Regina and Korneeva, Olga S and Duvigneau, Johanna Catharina and Marolt Presen, Darja and Kozlov, Andrey V},
title = {Osteosarcoma Cells and Undifferentiated Human Mesenchymal Stromal Cells Are More Susceptible to Ferroptosis than Differentiated Human Mesenchymal Stromal Cells},
journal = {Antioxidants},
year = {2025},
volume = {14},
number = {2},
pages = {189},
doi = {10.3390/antiox14020189}
}
EUVIMED